GoldenGolden
Second Genome

Second Genome

Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.

Second Genome is a company that has the mission to redefine disease in terms of microbiome medicine. It uses proprietary microbiome drug discovery and development platform to find effective peptides, proteins and small molecule therapeutics.

Timeline

April 2016
Second Genome raises a $51,000,000 series B round from Digitalis Ventures, LifeForce Capital, Matthew Winkler, Mayo Clinic, Morgenthaler Ventures, Pfizer Venture Investments, Roche Venture Fund, Seraph Group and Sr One.
June 5, 2013
Second Genome raises a $11,500,000 series A round from Advanced Technology Ventures and Morgenthaler Ventures.
August 9, 2011
Second Genome raises a $4,999,999 series A round from Advanced Technology Ventures, Morgenthaler Ventures, Seraph Group and Wavepoint Ventures.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Second Genome Series B round, April 2016
51,000,000
April 2016
3 Results
Results per page:
Page 1 of 1

SBA Awards

SBA Award
Agency
Award Type
Amount (USD)
Date Awarded
Second Genome, Inc. SBIR Phase II Award, January 2019
SBIR
977,355
January 15, 2019
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Adam Altrichter

Employee

Ali A. Faruqi

Employee

Amit Bansal

Investor

Andrew Han

Employee

Anh Vu

Employee

Bettina John

Employee

Cara Cheng

Employee

Daniel Morton

Employee

Darren Tsang

Employee

Drew Taylor

Investor

Gregory Tang

Employee

Inessa O-Childs

Investor

Kaitlin Flynn

Employee

Paul Connors

Investor

Steven McColloch

Employee

Sunit Jain

Employee

Taru G

Employee

Tuff Yen

Investor

Tyler Dorman

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.